Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-18 | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 14400 | $9.26 - $9.26 | $133,293 |
2024-11-18 | KalVista Pharmaceuticals, Inc. | Yea Christopher
(CHIEF DEVELOPMENT OFFICER) |
S | Common Stock | D | 7192 | $9.26 - $9.26 | $66,572 |
2024-11-18 | KalVista Pharmaceuticals, Inc. | Audhya Paul K.
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 8077 | $9.26 - $9.26 | $74,765 |
2024-09-09 | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 7352 | $12.19 - $12.19 | $89,621 |
2024-08-23 | KalVista Pharmaceuticals, Inc. | Audhya Paul K.
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 2135 | $12.40 - $12.40 | $26,474 |
2024-08-23 | KalVista Pharmaceuticals, Inc. | Yea Christopher
(CHIEF DEVELOPMENT OFFICER) |
S | Common Stock | D | 1916 | $12.40 - $12.40 | $23,758 |
2024-08-19 | KalVista Pharmaceuticals, Inc. | Audhya Paul K.
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 7973 | $12.01 - $12.01 | $95,782 |
2024-08-19 | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 14215 | $12.01 - $12.01 | $170,769 |
2024-08-19 | KalVista Pharmaceuticals, Inc. | Yea Christopher
(CHIEF DEVELOPMENT OFFICER) |
S | Common Stock | D | 7102 | $12.01 - $12.01 | $85,318 |
2024-06-07 | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 7465 | $11.53 - $11.53 | $86,068 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |